Molecular mechanisms of neonatal brain injury

Claire Thornton1, Catherine I Rousset, Anton Kichev

  • 1Centre for the Developing Brain, Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.

Insights

Fetal/neonatal brain injury causes long-term disability. Understanding delayed injury phases, like mitochondrial dysfunction, allows for new neuroprotective treatments days after the initial insult.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Pathophysiology

Background:

  • Fetal/neonatal brain injury is a major cause of neurological disability.
  • Hypoxia-ischemia and excitotoxicity are key insults leading to injury.
  • Brain damage progresses over primary, secondary, and tertiary phases after the insult.

Purpose of the Study:

  • To explore pathophysiological mechanisms during secondary and tertiary phases of brain injury.
  • To identify potential therapeutic targets for neuroprotection beyond the acute phase.
  • To review molecular events in secondary phase injury, including mitochondrial dysfunction and apoptosis.

Main Methods:

  • Literature review of pathophysiological mechanisms in fetal/neonatal brain injury.
  • Analysis of molecular events during the secondary phase of injury.
  • Examination of recent evidence for delayed therapeutic interventions.

Main Results:

  • Brain injury develops over a protracted period, with delayed progression.
  • Mitochondrial dysfunction and apoptosis are critical in the secondary phase of injury.
  • Interventions may be effective days to weeks after the initial insult.

Conclusions:

  • Delayed injury progression offers a therapeutic window for neuroprotection.
  • Targeting secondary phase mechanisms like mitochondrial dysfunction is crucial.
  • Developing next-generation treatments requires understanding these later injury phases.